All Antimicrobials articles – Page 9
-
NewsWomen need better treatments for bacterial vaginosis: call
Researchers at the University of Maryland School of Medicine are calling for robust studies for a treatment already used in Europe.
-
NewsResearchers discover key functions of therapeutically promising jumbo viruses
Identifying core replication processes has moved scientists closer to tapping phage as a treatment in the growing antibiotic resistance crisis.
-
NewsAntimicrobial peptide from cows delivers way to kill hypervirulent bacteria
An antimicrobial peptide from cows has potential for treating incurable infections from the bacterium Klebsiella pneumoniae.
-
NewsPioneering oral fungal infection treatment shows promise in preclinical trials
A novel oral amphotericin B (MAT2203) developed for treatment of invasive mucormycosis (IM) and other deadly invasive fungal infections, has demonstrated encouraging results in a series of preclinical studies.
-
NewsThyme essential oil inhibits staph biofilm formation
Thyme essential oil shows efficacy in inhibiting the biofilm formation of Staphylococcus aureus at a concentration of 0.03% (v/v), a new study being presented at Letters in Applied Microbiology ECS Research Symposium has revealed.
-
NewsCompeting bacteria yield possible alternative to antibiotics
Scientists have discovered a new so-called lantibiotic, namely epilancin A37. It is produced by staphylococci that colonize the skin and acts specifically against their main competitors there, the corynebacteria.
-
NewsTropical red seaweed protects Ostrea edulis larvae against pathogen
A new study finds that extracts of tropical red seaweed Acanthophora spicifera are a natural alternative for pathogen control management in O. edulis cultures.
-
NewsExperts developing immune-enhancing therapies to target tuberculosis
Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body’s own immune system to target tuberculosis, with hopes that they could tackle even the drug-resistant forms of the disease.
-
NewsOptimal timing maximises Paxlovid benefits for treating COVID-19
Study suggests using the anti-COVID-19 treatment Paxlovid three to five days after symptoms emerge in patients and expanding global access to the drug may help reduce the severity and transmission of the SARS-CoV-2 virus.
-
NewsNew class of antimicrobials discovered in soil bacteria
Scientists have mined Streptomyces for antibiotics for nearly a century, but the newly identified umbrella toxin escaped notice.
-
NewsCopper beads in pig feed reshape swine gut microbiome
New findings show copper beads influence the microbial makeup in a pig’s gut, but more work is needed to optimize the benefits.
-
CareersDIY beeswax food wraps could be a lifesaver in conflict regions like Ukraine
Home-made antimicrobial beeswax food wraps containing locally sourced herbs could provide low cost food storage in areas of Ukraine where the power supply has been disrupted by the Russian invasion.
-
NewsNanoparticle enhances antibacterial sonodynamic therapy for eradication of Pseudomonas aeruginosa biofilm
A novel ultrasound-launched targeted nanoparticle was developed to universally destroy biofilm, target bacteria, deliver antibiotics, and efficiently kill bacteria via ultrasonic cavitation and antibacterial sonodynamic therapy.
-
NewsStudy confirms how RNA chemical modifications benefit HIV-1
A chemical modification in the HIV-1 RNA genome whose function has been a matter of scientific debate is now confirmed to be key to the virus’s ability to survive and thrive after infecting host cells, a new study has found.
-
NewsInnovative antiviral defense with new CRISPR tool
Scientists outline how they have overcome a significant obstacle that has hampered the effectiveness of Cas13d: its restriction to the nucleus of mammalian cells.
-
NewsStudy describes strategy for inactivation of multidrug-resistant bacteria
Zinc oxide nanoparticles with varying morphologies were tested against microorganisms isolated from patients.
-
NewsA combination of approved drugs enhances the delivery of anti-bacterial medications to treat tuberculosis
Scientists repurposed approved drugs that they originally tested to normalize blood vessels surrounding tumors to improve drug delivery to cancer cells.
-
NewsSilicon spikes skewer 96% of virus particles
An international research team has designed and manufactured a virus-killing surface that could help control disease spread in hospitals, labs and other high-risk environments.
-
NewsMaleimide derivative shows promise for treating clinical candidiasis
A new study demonstrates the efficacy of a novel maleimide analogue as a novel antifungal compound, highlighting its potential as a promising option for the treatment of clinical candidiasis.
-
NewsBreakthrough antibiotic shows promise against obstinate mycobacterial infections
Researchers assemble a new antibiotic candidate, COE-PNH2, offering a more effective therapeutic option against hard-to-treat mycobacterial lung diseases.